Status:
COMPLETED
Imaging of Vitreous Opacities in Human Eyes
Lead Sponsor:
PulseMedica
Conditions:
Floaters
Vitreous Opacities
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Vitreous opacities (VOs), commonly known as floaters, are dark spots that appear in, and may float across your vision. Presently, there is a lack of available data in the literature regarding VOs. Thi...
Eligibility Criteria
Inclusion
- Aged 18 years or older
- SVO-related symptoms in vision
- Clear ocular media, to allow a clear view of the vitreous for the SVO-ID
Exclusion
- Presence of vitreous hemorrhage
- Cataract Grade 3 and above
- Opacification of lens, cornea, or vitreous
- Diagnosis of narrow-angle glaucoma
- Refractive error is outside the range of -6D to +3D
- Astigmatism is outside the range of +/- 2D of cylinder
Key Trial Info
Start Date :
April 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 18 2025
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT06097897
Start Date
April 1 2024
End Date
March 18 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Panama Eye Center
Panama City, Panama